IPO registrations (S-1, F-1) · Registrants
ONCOGENEX TECHNOLOGIES INC
- SEC CIK
- 1266677 · filings on EDGAR ↗
- Registration
- Form F-1, first filed 2006-12-13, last 2007-03-01; 1 initial registration, 4 amendments
- Outcome
- Declared effective 2007-03-05; withdrawal requested 2007-03-07
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Business address
- 1001 WEST BROADWAY, SUITE 400, Vancouver, A1 V6H 4B1
- EDGAR entity type
- other
Offering terms
- Proposed price range
- $7.50–$8.50 per share (F-1/A filed 2007-03-01)
- Shares offered
- 5,000,000
- Listing
- Nasdaq under the symbol OGXI
- Lead underwriters
- RBC Capital Markets; Needham & Company; Lazard; Canaccord Genuity
- Syndicate
- Susquehanna Financial Group, Lllp
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2006-12-13 | F-1 | F-1 (foreign registration) | ONCOGENEX TECHNOLOGIES INC | 0001047469-06-014943 ↗ |
| 2007-01-29 | F-1/A | F-1/A (amendment) | ONCOGENEX TECHNOLOGIES INC | 0001047469-07-000442 ↗ |
| 2007-02-05 | F-1/A | F-1/A (amendment) | ONCOGENEX TECHNOLOGIES INC | 0001047469-07-000595 ↗ |
| 2007-02-23 | F-1/A | F-1/A (amendment) | ONCOGENEX TECHNOLOGIES INC | 0001047469-07-001381 ↗ |
| 2007-03-01 | F-1/A | F-1/A (amendment) | ONCOGENEX TECHNOLOGIES INC | 0001047469-07-001508 ↗ |
| 2007-03-05 | EFFECT | EFFECT (declared effective) | ONCOGENEX TECHNOLOGIES INC | 9999999995-07-000839 ↗ |
| 2007-03-07 | RW | RW (withdrawal request) | ONCOGENEX TECHNOLOGIES INC | 0001104659-07-017112 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2007-03-01 | F-1/A | registration statement | $7.50–$8.50 | 5,000,000 | - | Nasdaq OGXI | 5 | primary document; range, shares headline, cover names 5 | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Others with the same interests
SIC industry Pharmaceutical Preparations, A1 first:
- Aspreva Pharmaceuticals CORP A1
- Lexaria Bioscience Corp. A1
- Zymeworks BC Inc. A1
- BetterLife Pharma Inc. A1
- ABATTIS BIOCEUTICALS CORP A1
- BriaCell Therapeutics Corp. A1
- Old API Wind-down Ltd. A1
- AbCellera Biologics Inc. A1
- BODY & MIND INC. A1
- XORTX Therapeutics Inc. A1
In other datasets, the same topic (Health) in A1:
- Form D issuer: 1219014 B.C. Ltd. (Form D private offerings)
Interests: Pharmaceutical Preparations · Health